2189 ⎘
Genetically modified animals Animals comprising multiple alterations of the genome, by transgenesis or homologous recombination, e.g. obtained by cross-breeding
GENETICALLY MODIFIED T CELL RECEPTOR MICE
#2MOUSE MODEL OF DITRA DISEASE AND USES THEREOF
#3HUMANIZED LIGHT CHAIN MICE
#4HUMANIZATION OF BETA2-MICROGLOBULIN IN PORCINE GENOME RESULTING IN FUNCTIONAL EXPRESSION OF HUMAN BETA2-MICROGLOBULIN WITHIN DONOR CELLS, TISSUES, OR ORGANS
#5Non-Human Animals Expressing pH-Sensitive Immunoglobulin Sequences
#6IMMUNODEFICIENT NON-HUMAN ANIMALS FOR ASSESSING DRUG METABOLISM AND TOXICITY
#7Genetically Modified Mice and Engraftment
#8GENETICALLY MODIFIED CELLS, TISSUES, AND ORGANS FOR TREATING DISEASE
#9METHODS AND MODELS FOR ASSESSING EFFICACY OF IMMUNOTHERAPIES
#10CONSTRUCTION METHOD AND USE OF Thy1-SNCA; Clu GENE KNOCKOUT MOUSE MODEL
#11NON-HUMAN ANIMALS HAVING AN ENGINEERED IMMUNOGLOBULIN LAMBDA LIGHT CHAIN AND USES THEREOF
#12COMMON LIGHT CHAIN MOUSE
#13NON-HUMAN ANIMALS EXPRESSING EXOGENOUS TERMINAL DEOXYNUCLEOTIDYLTRANSFERASE
#14CONFINABLE POPULATION SUPPRESSION SYSTEM
#15HUMANIZED IL-6 AND IL-6 RECEPTOR
#16METHODS FOR PRODUCING ANTIGEN-BINDING PROTEINS AGAINST FOREIGN ANTIGENS
#17GENETICALLY MODIFIED MOUSE MODELS OF ALZHEIMER’S DISEASE
#18THERAPIES WITH LANTHIONINE C-LIKE PROTEIN 2 LIGANDS AND CELLS PREPARED THEREWITH
#19TRIPLE TRANSGENIC PIGS SUITABLE FOR XENOGRAFT
#20Genetic Modifications for Xenotransplantation
#21A NON-HUMAN MAMMAL COMPRISING IN ITS GENOME AT LEAST TWO HUMAN LEUKOCYTE ANTIGEN (HLA) CLASS I ALLELES, METHODS OF MAKING SUCH MAMMAL AND USES THEREOF
#22Humanized M-CSF Mice
#23Genetically Modified Non-Human Animals And Methods Of Use Thereof
#24TRANSGENIC MICE WITH HUMANIZED MHC I AND IMMUNOGLOBLUIN HEAVY CHAIN GENES
#25TRANSGENIC MICE WITH HUMANIZED MHC I AND IMMUNOGLOBLUIN HEAVY CHAIN GENES
#26LOW AFFINITY FcyR DEFICIENT MICE
#27NEURODEGENERATIVE AND AMYOTROPHIC MODEL ANIMAL
#28NON-HUMAN ANIMALS HAVING A HUMANIZED LYMPHOCYTE-ACTIVATION GENE 3
#29GENETICALLY MODIFIED MOUSE THAT EXPRESSES HUMANIZED PD1 AND PD-L1 PROTEINS
#30METHODS FOR MAKING GENETIC EDITS
#31HUMAN ANTIBODIES FROM TRANSGENIC RODENTS WITH MULTIPLE HEAVY CHAIN IMMUNOGLOBULIN LOCI
#32TRANSGENIC ANIMAL MODEL, METHOD FOR CONSTRUCTING SAME, AND USE THEREOF
#33METHODS AND COMPOSITIONS FOR MODIFYING A TARGETED LOCUS
#34HUMAN LAMBDA LIGHT CHAIN MICE
#35GENETICALLY MODIFIED MOUSE EXPRESSING HUMAN APOE4 AND MOUSE TREM2 P.R47H AND METHODS OF USE THEREOF
#36ADAM6 MICE
#37Non-Human Animals Expressing Humanized CD3 Complex
#38METHODS AND COMPOSITIONS FOR INSERTION OF ANTIBODY CODING SEQUENCES INTO A SAFE HARBOR LOCUS
#39METHODS OF TREATING MITOCHONDRIAL DISORDERS
#40IMMUNOTHERAPY COMPOSITIONS AND METHODS FOR TREATMENT OF TAUOPATHY AND TRANSGENIC MOUSE
#41PORCINE REPRODUCTIVE AND RESPIRATORY SYNDROME VIRUS RESISTANT ANIMALS
#42ANTIBODY PRODUCTION
#43SGRNA AND CONSTRUCTING DUAL PIG MODEL OF SEVERE IMMUNODEFICIENCY AND LIVER INJURY AND USE THEREOF
#44METHOD FOR PREPARING TRANSGENIC NON-HUMAN ANIMAL HAVING GENOME INCLUDING HUMANIZED IMMUNOGLOBULIN GENE LOCUS
#45ENGINEERED NON-HUMAN ANIMALS FOR PRODUCING ANTIBODIES
#46IL-17A BINDING PROTEINS
#47IMMUNOTHERAPY COMPOSITIONS AND METHODS FOR TREATMENT OF TAUOPATHY AND TRANSGENIC MOUSE
#48DOUBLE KNOCKOUT (GT/CMAH-KO) PIGS, ORGANS AND TISSUES
#49GENETICALLY ENGINEERED SWINE FOR PRECLINICAL VALIDATION
#50ANTIBODY PRODUCING NON-HUMAN ANIMALS
#51ANTIBODY PRODUCING NON-HUMAN ANIMALS
#52COMMON LIGHT CHAIN MOUSE
#53GENETICALLY MODIFIED RAT MODELS FOR SEVERE COMBINED IMMUNODEFICIENCY (SCID)
#54NON-HUMAN ANIMALS HAVING A HUMANIZED CLUSTER OF DIFFERENTIATION 47 GENE
#55Genetically modified non-human having humanized gamma and delta TCR variable genes
#56TRPC3 AS A THERAPEUTIC TARGET FOR ALZHEIMER’S DISEASE
#57CAS-READY MOUSE EMBRYONIC STEM CELLS AND MICE AND USES THEREOF
#58METHOD OF PREPARING ANTIBODY CARRYING A UNIVERSAL SITE-DIRECTED COUPLING INTERFACE BASED ON GENETICALLY MODIFIED VERTEBRATE
#59GENETICALLY MODIFIED NON-HUMAN ANIMALS EXPRESSING HUMAN EPO
#60HUMANIZED NON-HUMAN ANIMALS WITH RESTRICTED IMMUNOGLOBULIN HEAVY CHAIN LOCI
#61Animal Models and Therapeutic Molecules
#62ANTIBODY PRODUCING NON-HUMAN ANIMALS
#63HEAVY CHAIN-ONLY ANTIBODIES
#64Gene Expression System
#65GENETICALLY MODIFIED NON-HUMAN ANIMAL WITH HUMAN OR CHIMERIC GLP1R
#66Method of treating rheumatoid arthritis using antibodies to oxidized phospholipids
#67HUMANIZED LIGHT CHAIN MICE
#68ANIMAL MODEL, METHODS FOR MAKING AND USING THEREOF, AND COMPOSITION FOR TREATING ATAXIA
#69GENETICALLY MODIFIED NON-HUMAN ANIMALS AND METHODS OF USE THEREOF
#70HUMANIZED RODENTS FOR TESTING THERAPEUTIC AGENTS
#71Animal Models and Therapeutic Molecules
#72Animal Models and Therapeutic Molecules
#73ANIMAL MODEL OF BRAIN TUMOR AND MANUFACTURING METHOD OF ANIMAL MODEL
#74GENETICALLY MODIFIED NON-HUMAN ANIMAL EXPRESSING A B2M/FCRN FUSION PROTEIN
#75Methods and compositions for modified factor IX fusion proteins
#76TISSUE SELECTIVE TRANSGENE EXPRESSION
#77MOUSE MODEL OF DITRA DISEASE AND USES THEREOF
#78GENETICALLY MODIFIED NON-HUMAN ANIMAL WITH HUMAN OR CHIMERIC CD94 AND/OR NKG2A
#79NON-HUMAN ANIMALS HAVING A HUMANIZED CXCL13 GENE
#80ANIMAL MODELS AND THERAPEUTIC MOLECULES
#81GENETICALLY MODIFIED NON-HUMAN ANIMAL WITH HUMAN OR CHIMERIC CD38
#82NON-HUMAN ANIMAL SECRETOME MODELS
#83TRANSGENIC MICE
#84TGFbeta1 Hyperactivation Causes Gender-Specific Calcific Aortic Stenosis
#85ANTI-MUC16 ANTIBODIES AND USES THEREOF
#86THYMUS ORGANOIDS BIOENGINEERED FROM HUMAN PLURIPOTENT STEM CELLS
#87HUMANIZED UNIVERSAL LIGHT CHAIN MICE
#88GENETICALLY MODIFIED T CELL RECEPTOR MICE
#89A METHOD OF GENERATING STERILE PROGENY
#90HUMANIZED TRANSGENIC MOUSE MODEL
#91SYSTEMS AND METHODS FOR IN VIVO DUAL RECOMBINASE-MEDIATED CASSETTE EXCHANGE (dRMCE) AND DISEASE MODELS THEREOF
#92Transgenic Non-Human Vertebrate for the Expression of Class-Switched, Fully Human, Antibodies
#93ANIMAL MODEL OF IDIOPATHIC PULMONARY FIBROSIS, ITS CONSTRUCTION METHOD AND USE
#94CELLS, TISSUES, ORGANS, AND/OR ANIMALS HAVING ONE OR MORE MODIFIED GENES FOR ENHANCED XENOGRAFT SURVIVAL AND/OR TOLERANCE
#95Platform for T lymphocyte genome engineering and in vivo high-throughput screening thereof
#96METHODS FOR MODIFYING A GENOME
#97Rodent Model Of Increased Bone Mineral Density
#98Non-Human Animals Expressing pH-Sensitive Immunoglobulin Sequences
#99GENETICALLY MODIFIED NON-HUMAN ANIMAL WITH HUMAN OR CHIMERIC CD73
#100Identification of porcine xenoantigens
#101RESTRICTED IMMUNOGLOBULIN HEAVY CHAIN MICE
#102NON-HUMAN ANIMALS HAVING AN IMMUNOGLOBULIN HEAVY CHAIN VARIABLE REGION THAT INCLUDES AN ENGINEERED DIVERSITY CLUSTER AND USES THEREOF
#103METHODS FOR PRODUCING ANTIGEN-BINDING PROTEINS AGAINST FOREIGN ANTIGENS
#104Genetically modified rat models for severe combined immunodeficiency (SCID)
#105ANIMAL MODEL FOR DRUG DEVELOPMENT
#106GENETICALLY MODIFIED CELLS, TISSUES, AND ORGANS FOR TREATING DISEASE
#107Therapies with lanthionine C-like protein 2 ligands and cells prepared therewith
#108Methods for making genetic edits
#109Humanized IL-6 and IL-6 receptor
#110NON-HUMAN ANIMALS EXPRESSING HUMANIZED C1Q COMPLEX
#111Methods of treating mitochondrial disorders
#112MANIPULATION OF IMMUNOGLOBULIN GENE DIVERSITY AND MULTI-ANTIBODY THERAPEUTICS
#113Genetically Modified Mice and Engraftment
#114Siglec transgenic mice and methods of use thereof
#115METHODS, COMPOSITIONS AND SYSTEMS FOR PRODUCTION OF RECOMBINANT SPIDER SILK POLYPEPTIDES
#116ANTIGEN-BINDING MOLECULES COMPRISING UNPAIRED VARIABLE DOMAINS
#117Genetically modified rat models for severe combined immunodeficiency (SCID)
#118Cas-ready mouse embryonic stem cells and mice and uses thereof
#119Genetically modified non-human animals and methods of use thereof
#120HUMANIZED RODENTS THAT EXPRESS HEAVY CHAIN CONTAINING VL DOMAINS
#121Non-human animals having a humanized lymphocyte-activation gene 3
#122NON-HUMAN ANIMALS THAT SELECT FOR LIGHT CHAIN VARIABLE REGIONS THAT BIND ANTIGEN
#123Methods of using humanized FCγR mice to assay Fc regions
#124Genetically modified sterile avians and method for the reconstitution thereof
#125NON-HUMAN ANIMALS HAVING AN ENGINEERED IMMUNOGLOBULIN LAMBDA LIGHT CHAIN AND USES THEREOF
#126MICE EXPRESSING A LIMITED IMMUNOGLOBULIN LIGHT CHAIN REPERTOIRE
#127Non-human animals models of retinoschisis
#128NON-HUMAN ANIMALS HAVING AN ENGINEERED IMMUNOGLOBULIN LAMBDA LIGHT CHAIN AND USES THEREOF
#129PORCINE REPRODUCTIVE AND RESPIRATORY SYNDROME VIRUS RESISTANT ANIMALS
#130POLYNUCLEOTIDE
#131A TRANSGENIC INVERTEBRATE MODEL FOR ALZHEIMER'S DISEASE AND USE THEREOF
#132TRANSGENIC CHICKEN HAVING AN ENDOGENOUS IMMUNOGLOBULIN HEAVY CHAIN GENE IN WHICH THE IGY CH1 CODING SEQUENCE IS FUNCTIONALLY DELETED
#133COMMON LIGHT CHAIN MOUSE
#134Animal models and therapeutic molecules
#135GENETICALLY MODIFIED MOUSE MODELS OF ALZHEIMER'S DISEASE
#136Non-human animals expressing exogenous terminal deoxynucleotidyltransferase
#137HUMANIZED HEART MUSCLE
#138Mouse having a humanized cluster of differentiation 47 gene
#139Humanized skeletal muscle
#140Gene expression system
#141Genetic modification of rats
#142Humanized M-CSF mice
#143ADAM6 mice
#144ADAM6 mice
#145Genetically modified mouse that expresses humanized PD1 and PD-L1 proteins
#146IMMUNODEFICIENT NON-HUMAN ANIMAL
#147Non-human animals expressing humanized CD3 complex
#148Genetically modified non-human animals and methods of use thereof
#149NOVEL IMMUNODEFICIENT RAT FOR MODELING HUMAN CANCER
#150Double knockout (GT/CMAH-KO) pigs, organs and tissues
#151ADAM6 KNOCKIN MICE
#152GENETICALLY MODIFIED T CELL RECEPTOR MICE
#153Transgenic animals and methods of use
#154INDUCIBLE DISEASE MODELS METHODS OF MAKING THEM AND USE IN TISSUE COMPLEMENTATION
#155Reelin antibodies for treatment of atherosclerosis
#156Nucleic acid molecules and applications thereof in human antibody
#157Population control using engineered translocations
#158CANCER IMAGING WITH THERAPY: THERANOSTICS
#159GENETICALLY MODIFIED MAJOR HISTOCOMPATIBILITY COMPLEX MICE
#160GENETICALLY MODIFIED MAJOR HISTOCOMPATIBILITY COMPLEX ANIMALS
#161Animal Models and Therapeutic Molecules
#162HUMANIZED TRANSGENIC ANIMAL
#163Animal Models and Therapeutic Molecules
#164Animal Models and Therapeutic Molecules
#165Genetically modified cells, tissues, and organs for treating disease
#166IL-17A binding proteins
#167Animal Models and Therapeutic Molecules
#168METHODS AND COMPOSITIONS FOR INSERTION OF ANTIBODY CODING SEQUENCES INTO A SAFE HARBOR LOCUS
#169Transgenic mammals and methods of use thereof
#170Transgenic chicken comprising an inactivated immunoglobulin gene
#171Peromyscus animal model for cancer
#172LOSS OF FUNCTION RODENT MODEL OF SOLUTE CARRIER 39 MEMBER 5
#173Humanized non-human animals with restricted immunoglobulin heavy chain loci
#174Restricted Immunoglobulin Heavy Chain Mice
#175Non-human animals expressing humanized CD3 complex
#176HUMAN LAMBDA LIGHT CHAIN MICE
#177HUMAN ARTIFICIAL CHROMOSOME CONTAINING HUMAN ANTIBODY LAMBDA LIGHT CHAIN GENE AND NON-HUMAN ANIMAL CONTAINING THE HUMAN ARTIFICIAL CHROMOSOME CAPABLE OF GENETIC TRANSMISSION
#178Genetically modified non-human animals and methods of use thereof
#179Humanized light chain mice
#180Humanized light chain mice
#181CELLS, VERTEBRATES, POPULATIONS & METHODS
#182Transgenic Animals
#183MICRO-RNA FAMILY THAT MODULATES FIBROSIS AND USES THEREOF
#184REPROGRAMMING METABOLISM BY INHIBITING VHL FOR TREATMENT OF NEURODEGENERATION
#185TISSUE SELECTIVE TRANSGENE EXPRESSION
#186Human antibodies from transgenic rodents with multiple heavy chain immunoglobulin loci
#187TRPC3 as a therapeutic target for alzheimer's disease
#188Porcine reproductive and respiratory syndrome virus resistant animals
#189Anti-tumor properties of Dickkopf 3b
#190Recombinant adenovirus-based interferon biotherapeutics in swine
#191Genetically modified non-human animals and methods of use thereof
#192Stable transformation of a population and a method of biocontainment using haploinsufficiency and underdominance principles
#193Methods for autocatalytic genome editing and neutralizing autocatalytic genome editing and compositions thereof
#194Transgenic biosensor
#195Humanized low affinity FCγR mouse cells
#196NSG mice lacking MHC class I and class II
#197Genetically modified non-human animals expressing human EPO
#198Mice expressing a limited immunoglobulin light chain repertoire
#199Genetically modified mouse expressing human APOE4 and mouse Trem2 p.R47H and methods of use thereof
#200Genetically modified non-human animal with human or chimeric PD-L1
#201ENGINEERING OF HUMANIZED CAR T-CELL AND PLATELETS BY GENETIC COMPLEMENTATION
#202Mouse model of DITRA disease and uses thereof
#203Humanized IL-6 and IL-6 receptor
#204Multifunctional alleles
#205METHOD FOR ASSAYING GENETIC VARIANTS
#206Genetically modified non-human animal with human or chimeric PD-1
#207DMD REPORTER MODELS CONTAINING HUMANIZED DUCHENNE MUSCULAR DYSTROPHY MUTATIONS
#208ANIMAL MODEL FOR DRUG DEVELOPMENT
#209Method for constructing PD-1 gene modified humanized animal model and use thereof
#210GENETICALLY MODIFIED CELLS, TISSUES, AND ORGANS FOR TREATING DISEASE
#211Urokinase-type plasminogen activator transgenic mouse
#212Animal models and therapeutic molecules
#213HUMANIZED MOUSE MODEL WITH IMPROVED HUMAN INNATE IMMUNE CELL DEVELOPMENT
#214Non-human animals having a humanized lymphocyte-activation gene 3
#215Immunodeficient non-human animal
#216Genetic modification of rats
#217Genetically modified mice and engraftment
#218Genetically modified mouse with humanized immunoglobulin heavy chain constant region genes and method of using
#219Genetically modified non-human animal with human or chimeric PD-L1
#220ANIMAL MODELS OF CANCER
#221Restricted immunoglobulin heavy chain mice
#222Engineering of Humanized Kidney by Genetic Complementation
#223Genetically modified cells, tissues, and organs for treating disease
#224METHODS AND COMPOUNDS FOR GENE INSERTION INTO REPEATED CHROMOSOME REGIONS FOR MULTI-LOCUS ASSORTMENT AND DAISYFIELD DRIVES
#225IDENTIFICATION OF PORCINE XENOANTIGENS
#226Methods and compositions for modifying a targeted locus
#227Mouse having an engineered immunoglobulin lambda light chain
#228METHOD FOR ESTABLISHING A NON-HUMAN MAMMALIAN ANIMAL MODEL SUFFERING FROM OBESITY OR RELATED DISEASE AND USE THEREOF
#229Transgenic non-human vertebrate for the expression of class-switched, fully human, antibodies
#230HUMAN LAMBDA LIGHT CHAIN MICE
#231Compositions and methods for treating and preventing metabolic disorders
#232METHODS AND COMPOSITIONS RELATING TO IMPROVED HUMAN RED BLOOD CELL SURVIVAL IN GENETICALLY MODIFIED IMMUNODEFICIENT NON-HUMAN ANIMALS
#233ANIMAL MODELS FOR POLYCYSTIC KIDNEY DISEASE
#234Animal models and therapeutic molecules
#235Modulation of BCL11A for treatment of hemoglobinopathies
#236Therapies with lanthionine C-like protein 2 ligands and cells prepared therewith
#237HUMAN LAMBDA LIGHT CHAIN MICE
#238VE-PTP KNOCKOUT
#239GENERATION OF GENETICALLY ENGINEERED ANIMALS BY CRISPR/CAS9 GENOME EDITING IN SPERMATOGONIAL STEM CELLS
#240Humanized universal light chain mice
#241Co-activation of mTOR and STAT3 pathways to promote neuronal survival and regeneration
#242Methods of treating mitochondrial disorders
#243Methods, compositions and systems for production of recombinant spider silk polypeptides
#244Non-human animals expressing humanized C1Q complex
#245COMMON LIGHT CHAIN MOUSE
#246Genetically modified non-human animals and methods of use thereof
#247Mice expressing a limited immunoglobulin light chain repertoire
#248METHODS FOR MAKING FULLY HUMAN BISPECIFIC ANTIBODIES USING A COMMON LIGHT CHAIN
#249NON-HUMAN ANIMALS HAVING A MUTANT KYNURENINASE GENE
#250Compositions and methods for genetically modifying myosin phosphatase target subunit (Mypt1) gene for lowering blood pressure
#251Common light chain mouse
#252Cas-ready mouse embryonic stem cells and mice and uses thereof
#253Histidine Engineered Light Chain Antibodies and Genetically Modified Non-Human Animals for Generating the Same
#254Transgenic pig which simultaneously expresses HO-1 gene and TNFR1-Fc gene, and comprises knocked-out GGTA1 gene, and use thereof
#255COMMON LIGHT CHAIN MOUSE
#256Porcine reproductive and respiratory syndrome virus resistant animals
#257Transgenic mice
#258ADAM6 mice
#259ADAM6 mice
#260ADAM6 mice
#261ADAM6 mice
#262Antibodies to oxidized phospholipids
#263Antibodies to oxidized phospholipids
#264Model animal for fibrosis
#265Methods and compositions for modified factor IX fusion proteins
#266Animal models and therapeutic molecules
#267High-throughput mouse model for optimizing antibody affinities
#268Transgenic Animals
#269Genetically modified non-human animals and methods of use thereof
#270Genetically modified rat models for severe combined immunodeficiency (SCID)
#271Genetically modified major histocompatibility complex animals
#272Method for measuring tumor burden in patient derived xenograft (PDX) mice
#273Methods and compositions for treatment of atherosclerosis
#274Humanized IL-6 and IL-6 receptor
#275Antibodies to oxidized phospholipids
#276Non-human animal models of retinoschisis
#277Androgenetic haploid embryonic stem cell (AG-HAESC), and preparation method and use thereof
#278Method of using mouse having a humanized cluster of differentiation 47 gene
#279Multi-Transgenic Pig for Xenotransplantation
#280Non-human animals that select for light chain variable regions that bind antigen
#281MULTIPLEX GENE EDITING
#282ANTI-IL-17RA IMMUNOGLOBULIN SINGLE HEAVY VARIABLE DOMAIN ANTIBODIES
#283PCSK9 INHIBITORY POLYPOLYPEPTIDES AND METHODS OF USE
#284Peromyscus animal model for cancer
#285Methods and agents for treating Alzheimer's disease
#286Modulation of BCL11A for treatment of hemoglobinopathies
#287Humanized skeletal muscle
#288Humanized heart muscle
#289Micro-RNA family that modulates extracellular matrix genes and uses thereof
#290Genetically modified mouse whose genome comprises a humanized CD274 gene
#291Transgenic Immunodeficient Mouse Expressing Human SIRP-alpha
#292Siglec transgenic mice and methods of use thereof
#293Double knockout (GT/CMAH-KO) pigs, organs and tissues
#294ANTIBODY PRODUCING NON-HUMAN ANIMALS
#295ANTIBODY PRODUCING NON-HUMAN ANIMALS
#296Antibody producing non-human animals
#297ANTIBODY PRODUCING NON-HUMAN ANIMALS
#298Antibody producing non-human animals
#299Humanized T cell mediated immune responses in non-human animals
#300TRANSGENIC PRODUCTION OF FC FUSION PROTEINS